Annual report pursuant to Section 13 and 15(d)

Organization and Description of Business - Additional Information (Details)

v3.23.1
Organization and Description of Business - Additional Information (Details)
12 Months Ended
Nov. 01, 2022
USD ($)
Oct. 28, 2021
USD ($)
shares
Oct. 26, 2021
USD ($)
$ / shares
shares
Apr. 01, 2021
USD ($)
shares
Jan. 22, 2021
Item
Dec. 31, 2021
USD ($)
$ / shares
shares
Dec. 31, 2022
$ / shares
Business Acquisition [Line Items]              
Number of healthcare subsidiaries | Item         2    
Warrants to purchase shares of common stock | shares           1,648,873  
Common stock, par value | $ / shares           $ 0.0001 $ 0.0001
Price per share | $ / shares             $ 4.00
Proceeds from initial public offering           $ 25,378,663  
Initial Public Offering              
Business Acquisition [Line Items]              
Number of shares issued | shares   6,250,000          
Proceeds from initial public offering   $ 28,750,000          
Conversion of convertible notes to common stock in connection with initial public offering     $ 5,106,554        
Class A common stock | Initial Public Offering              
Business Acquisition [Line Items]              
Number of shares issued | shares     7,187,500        
Common stock, par value | $ / shares     $ 0.0001        
Price per share | $ / shares     $ 4.00        
Proceeds from initial public offering     $ 28,750,000        
Marpai Health              
Business Acquisition [Line Items]              
Options to purchase shares of common stock | shares       1,027,602      
Warrants to purchase shares of common stock | shares       1,366,746      
Conversion ratio       1      
Convertible promissory notes acquired       $ 2,198,459      
Amount of convertible promissory notes exchanged for shares of common stock       3,800,000      
Continental Benefits              
Business Acquisition [Line Items]              
Number of healthcare subsidiaries | Item         2    
Minimum cash on hand required at the time of closing of Acquisition       4,762,000      
Debt at the time of closing of Acquisition       0      
Purchase Price       $ 8,500,000      
Maestro              
Business Acquisition [Line Items]              
Purchase Price $ 19,900,000            
Adjusted Purchase Price $ 22,100,000            
Accrue interest percent 10.00%            
Percentage of net proceeds of the Offering 35.00%            
Number of days after closing of offering 60 days            
2024 $ 5,000,000            
2025 11,000,000            
2026 19,000,000            
2027 $ 28,000,000